.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Kikoko is stocked at 184 licensed dispensaries across California, with the deepest coverage in Los Angeles, Sacramento, San Diego, Santa Rosa, and Fresno. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Kikoko’s mix is concentrated in Capsules at 80.79% share with year-over-year decline of 40.80% and month-over-month slip of 1.38%, while Edible holds 15.11% share with a 2.20% year-over-year decline but an 8.93% month-over-month rise. Beverage sits at 4.10% share with a 39.92% year-over-year drop and an 11.69% month-over-month decline, and the brand’s average price fell 3.25% year over year alongside total brand sales down 37.00% year over year. With a rank of 6 in Capsules in California, the pattern implies a heavy dependence on a contracting Capsules base where price easing has not offset volume pressure, while Edible’s month-over-month lift signals the only near-term channel for stabilizing mix.
The shift—Capsules losing 40.80% year over year while Edible gains 8.93% month over month—implies Kikoko’s positioning is over-indexed to a segment with accelerating headwinds, and the 11.69% month-over-month decline in Beverage limits diversification. With Capsules still at 80.79% share versus Edible at 15.11%, the brand’s exposure remains concentrated; maintaining a rank of 6 in Capsules in California suggests relevance but not insulation, pointing to a need for mix rebalancing toward Edible where the sequential trend is positive despite a 2.20% year-over-year dip.
Competitive Landscape
Kikoko is ranked #6 in CA Capsules in August 2026, down 2 positions year over year from #4, and flat versus the prior three months at #6; this follows a peak at #4 in December 2025. In contrast, Emerald Bay Extracts climbed to #1 with a 5-position YoY rise from #6 alongside 71.2% YoY sales growth, while Level fell from #1 to #5 with a 4-position decline and a 59.3% YoY sales contraction, indicating share is rotating toward a leader while mid-tier positions churn. With Kikoko holding #6 in both May 2026 and August 2026 despite a YoY drop from #4, the pattern implies a stall in upward mobility: stability in the mid-tier but erosion versus faster-moving rivals.
Notable Products
Little Helpers - CBD/THC 3:1 Focus Mints 20-Pack (60mg CBD, 20mg THC) posted the steepest decline at -25.0% and slid to rank 9, while Little Helpers - Buzz Mints 20-Pack (100mg) fell -12.9% at rank 8; together these Edible setbacks contrast with Little Helpers - THC/THCV 1:1 Boost Matcha Botanical Mints 20-Pack (50mg THC, 50mg THCV) rising 39.5% to rank 7. XTabs - Sativa High Dose Tablets 20-Pack (1000mg) held rank 1 with +6.4% MoM and XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) dipped -8.8% at rank 3, reinforcing a Capsule concentration where three of the top five are Capsules even as Edibles occupy ranks 4, 6, 7, 8, and 9. The mixed movement—Capsules steady at the top and Edibles bifurcating between sharp losses and a +39.5% gain—implies Kikoko is leaning on high-dose Capsules for predictable velocity while selectively scaling differentiated Edibles to test incremental demand.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
